Continuum Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Continuum Advisory's IBB Position: Q1 2026 in Review

Continuum Advisory increased its iShares Biotechnology ETF (IBB) stake by 7.9% in Q1 2026, buying an estimated $38.3K and bringing the position to 3,046 shares worth $514K. The position accounts for 0.05% of the portfolio, ranked #279.

Continuum Advisory first reported a position in IBB in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.93M in Q2 2023. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

• Continuum Advisory held 3,046 shares of iShares Biotechnology ETF worth $514K as of Q1 2026.
• Continuum Advisory bought 224 iShares Biotechnology ETF shares in Q1 2026, an estimated $38.3K.
• iShares Biotechnology ETF made up 0.05% of Continuum Advisory's portfolio in Q1 2026, its #279 holding.
• Continuum Advisory first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 11 quarters since.
• Continuum Advisory's iShares Biotechnology ETF position peaked at $1.93M in Q2 2023.
• 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.